193 related articles for article (PubMed ID: 19588792)
1. Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).
Kevany S; Meintjes G; Rebe K; Maartens G; Cleary S
S Afr Med J; 2009 May; 99(5):320-5. PubMed ID: 19588792
[TBL] [Abstract][Full Text] [Related]
2. Cost and outcomes of paediatric antiretroviral treatment in South Africa.
Meyer-Rath G; Brennan A; Long L; Ndibongo B; Technau K; Moultrie H; Fairlie L; Coovadia A; Rosen S
AIDS; 2013 Jan; 27(2):243-50. PubMed ID: 23014517
[TBL] [Abstract][Full Text] [Related]
3. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
[TBL] [Abstract][Full Text] [Related]
4. The lifetime cost of current human immunodeficiency virus care in the United States.
Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
[TBL] [Abstract][Full Text] [Related]
5. Resource utilization and direct costs of pediatric HIV in Italy.
Giacomet V; Fabiano V; Lo Muto R; Caiazzo MA; Curto A; Rampon O; Zuccotti GV; Garattini L
AIDS Care; 2013; 25(11):1392-8. PubMed ID: 23414422
[TBL] [Abstract][Full Text] [Related]
6. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.
Rosen S; Long L; Sanne I
Trop Med Int Health; 2008 Aug; 13(8):1005-15. PubMed ID: 18631314
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization of patients accessing an African national treatment program.
Harling G; Orrell C; Wood R
BMC Health Serv Res; 2007 Jun; 7():80. PubMed ID: 17555564
[TBL] [Abstract][Full Text] [Related]
8. What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?
Aliyu HB; Chuku NN; Kola-Jebutu A; Abubakar Z; Torpey K; Chabikuli ON
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):221-5. PubMed ID: 22820805
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction with antiretroviral services at primary health-care facilities in the Free State, South Africa--a two-year study using four waves of cross-sectional data.
Wouters E; Heunis C; van Rensburg D; Meulemans H
BMC Health Serv Res; 2008 Oct; 8():210. PubMed ID: 18844998
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
[TBL] [Abstract][Full Text] [Related]
11. An economic case for providing free access to antiretroviral therapy for HIV-positive people in South Australia.
Heymer KJ; Wentzlaff-Eggebert M; Mortimer E; Wilson DP
Sex Health; 2012 Jul; 9(3):220-6. PubMed ID: 22697138
[TBL] [Abstract][Full Text] [Related]
12. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.
Krentz HB; Auld MC; Gill MJ;
CMAJ; 2003 Jul; 169(2):106-10. PubMed ID: 12874156
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of outpatient costs in HIV treatment programs.
Sarti FM; Nishijima M; Campino AC; Cyrillo DC
Rev Assoc Med Bras (1992); 2012; 58(5):561-7. PubMed ID: 23090227
[TBL] [Abstract][Full Text] [Related]
14. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
15. Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa.
Boulle A; Kenyon C; Skordis J; Wood R
S Afr Med J; 2002 Oct; 92(10):811-7. PubMed ID: 12432807
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of staff and workload profiles in retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa.
Vella V; Govender T; Dlamini SS; Moodley I; David V; Taylor M; Jinabhai CC
AIDS Care; 2011 Sep; 23(9):1146-53. PubMed ID: 21562993
[TBL] [Abstract][Full Text] [Related]
17. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
Krentz HB; Gill MJ
HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
[TBL] [Abstract][Full Text] [Related]
18. Association of antiretroviral therapy adherence and health care costs.
Nachega JB; Leisegang R; Bishai D; Nguyen H; Hislop M; Cleary S; Regensberg L; Maartens G
Ann Intern Med; 2010 Jan; 152(1):18-25. PubMed ID: 20048268
[TBL] [Abstract][Full Text] [Related]
19. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of tension-free vaginal tape surgery for urinary incontinence in an ambulatory regimen compared with hospital admission: a study of the minimization of costs of a public hospital in Spain.
Moreno K; Montesino M
Scand J Urol Nephrol; 2007; 41(5):392-7. PubMed ID: 17853045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
